Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

OCAT

Ocata Therapeutics, Inc. (OCAT)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OCAT
DataOraFonteTitoloSimboloCompagnia
22/02/201619:44Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:OCAT(MM)
16/02/201620:55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OCAT(MM)
12/02/201617:32Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OCAT(MM)
11/02/201622:39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OCAT(MM)
11/02/201619:12Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OCAT(MM)
10/02/201622:34Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:OCAT(MM)
10/02/201622:24Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OCAT(MM)
10/02/201615:48PR Newswire (US)Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiarie...NASDAQ:OCAT(MM)
10/02/201615:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OCAT(MM)
10/02/201615:21Edgar (US Regulatory)(25-NSE)NASDAQ:OCAT(MM)
10/02/201615:18Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OCAT(MM)
10/02/201615:03Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OCAT(MM)
22/01/201614:52PR Newswire (US)Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata TherapeuticsNASDAQ:OCAT(MM)
06/01/201622:05Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:OCAT(MM)
28/12/201514:00Business WireOcata Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem CellsNASDAQ:OCAT(MM)
04/12/201522:03The Motley FoolOcata Therapeutics Almost Doubled in November -- Here's WhyNASDAQ:OCAT(MM)
03/12/201514:30Business WireOcata’s Hemangio-derived Mesenchymal Cells Preserve Kidney Function & Extend Lifespan in Preclinical Model of Lupus NephritisNASDAQ:OCAT(MM)
24/11/201522:38PR Newswire (US)Harwood Feffer LLP Announces Investigation of Ocata Therapeutics, Inc.NASDAQ:OCAT(MM)
19/11/201522:13Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:OCAT(MM)
19/11/201520:28Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:OCAT(MM)
12/11/201522:09Business WireOCATA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Ocata Therapeutics, Inc. (OCAT) Over the Propos...NASDAQ:OCAT(MM)
11/11/201519:09Business WireOCATA THERAPEUTICS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe & Powers Taylor LLP Investigate Merger with As...NASDAQ:OCAT(MM)
11/11/201500:23PR Newswire (US)SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ocata Therapeutics, Inc. of Commencement of an Investigatio...NASDAQ:OCAT(MM)
10/11/201522:32Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:OCAT(MM)
10/11/201521:27Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:OCAT(MM)
10/11/201521:03Business WireSHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Ocata Therapeutics, Inc. And Encourages ...NASDAQ:OCAT(MM)
10/11/201517:55Business WireINVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ocata Therapeutics, Inc. of Commencement of an Investigation I...NASDAQ:OCAT(MM)
10/11/201504:05PR Newswire (US)Astellas to Acquire Ocata TherapeuticsNASDAQ:OCAT(MM)
09/11/201514:03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OCAT(MM)
06/11/201522:52Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OCAT(MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OCAT
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network